Depletion of glutathione by benzo(a)pyrene metabolites, ionomycin, thapsigargin, and phorbol myristate in human peripheral blood mononuclear cells

Toxicology and Applied Pharmacology

Volumn 144, Issue 1, 1997, Pages 62-69

  Romero, David L ^a   Mounho, Barbara J ^a   Lauer, Fredine T ^a   Born, Jerry L ^a   Burchiel, Scott W ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; BENZO[A]PYRENE; BENZO[E]PYRENE; DRUG METABOLITE; GLUTATHIONE; IONOMYCIN; PHORBOL MYRISTATE; POLYCYCLIC AROMATIC HYDROCARBON; THAPSIGARGIN;

APOPTOSIS; ARTICLE; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOTOXICITY; LYMPHOCYTE; MONONUCLEAR CELL;

RODENTIA;

EID: 0031149019     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8113     Document Type: Article

References (58)

1. Abate C., Patel L., Rauscher F. J. III, Curran T. Redox regulation of Fos and Jun DNA-binding activity in vitro. Science. 24:1990;1157-1161.
2. Archuleta M. M., Schieven G. L., Ledbetter J. A., Deanin G. G., Burchiel S. W. 7,12-Dimethylbenz[a]anthracene activates protein-tyrosine kinases Fyn and Lck in the HPB-ALL human T-cell line and increases tyrosine phosphorylation of phospholipaseC-γ1, formation of inositol 1,4,5-triphosphate, and mobilization of intracellular calcium. Proc. Natl. Acad. Sci. USA. 90:1993;6105-6109.
3. ++. J. Biol. Chem. 259:1984;1279-1287.
4. Blumberg O. M. Protein kinase C as the receptor for the phorbol ester tumor promoters: Sixth Rhoads Memorial Award Lecture. Cancer Res. 48:1988;1-8.
5. Bowes R. C., Weber T. J., Ramos K. S. Induction of highly proliferative phenotypes in cultured glomerular mesangial cells by benzo[a]pyrene alone or in combination with methoxamine. Arch. Biochem. Biophys. 323:1995;243-250.
6. Burchiel S. W., Davis D. P., Ray S. D., Barton S. L. DMBA induces programmed cell death (apoptosis) in the A20.1 murine B cell lymphoma. Fundam. Appl. Toxicol. 21:1993;120-124.
7. Conney A. H., Chang R. L., Jerina D. M., Wei S.-J. C. Studies on the metabolism of benzo(a)pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite. Drug Metab. Rev. 26:1994;125-163.
8. Davila D. R., Davis D. P., Campbell K., Cambier J., Burchiel S. W. Role of altered calcium homeostasis and signal transduction in polycyclic aromatic hydrocarbon-induced immunotoxicity in B cells, invited review. J. Toxicol. Environ. Health. 45:1995;101-126.
9. Davila D. R., Romero D. L., Burchiel S. W. Human T cells are highly sensitive to suppression of mitogenesis by polycyclic aromatic hydrocarbons and this effect is differentially reversed by α-naphthoflavone. Toxicol. Appl. Pharmacol. 139:1996;333-341.
10. ++. Arch. Biochem. Biophys. 235:1984;343-350.
11. 2+. J. Immunol. 155:1995;5133-5139.
12. Fidelus R. K., Ginouves P., Lawrence D., Tsan M-F. Modulation of intracellular glutathione concentrations alters lymphocyte activation and proliferation. Exp. Cell Res. 170:1987;269-275.
13. Gelboin H. V. Benzo(a)pyrene metabolism, activation, and carcinogenesis: Role and regulation of mixed-function oxidases and related enzymes. Physiol. Rev. 60:1980;1107-1166.
14. Goujon F. M., Nebert D. W., Gielen J. E. Genetic expression or aryl hydrocarbon hydroxylase induction IV. Interaction of various compounds with different forms of cytochrome P-450 and the effects on benzo(a)pyrene metabolismin vitro. Mol. Pharmacol. 8:1972;667-680.
15. Griffin O. W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinlypyridine. Anal. Biochem. 106:1980;207-212.
16. Hallberg E., Rydstrom J. Selective oxidation of mitochondrial glutathione in cultured rat adrenal cells and its relation to polycyclic aromatic hydrocarbon-induced cytotoxicity. Arch. Biochem. Biophys. 270:1989;662-671.
17. Ho D., Fahl W. E. Modification of glutathione levels in C3H/10T1/2 cells and its relationship to benzo(a)pyreneanti. J. Biol. Chem. 259:1984;11231-11235.
18. Holsapple M. P., Karras J. G., Ledbetter J. A., Schieven G. L., Burchiel S. W., Davila D. R., Schatz A. R., Kaminski N. E. Molecular mechanisms of toxicant-induced immunosuppression: Role of second messengers. Annu. Rev. Pharmacol. Toxicol. 36:1996;131-159.
19. Kavanagh T. J., Grossmann A., Jaecks E. P., Jinneman J. C., Eaton D. L., Martin G. M., Rabinovitch P. S. Proliferative capacity of human peripheral blood lymphocytes sorted on the basis of of glutathione content. J. Cell. Physiol. 145:1990;472-480.
20. Kavanagh T. J., Grossmann A., Jinneman J. C., Kanner S. B., White C. C., Eaton D. L., Ledbetter J. A., Rabinovtich P. S. The effect of 1-chloro-2,4-dintrobenzene exposure on antigen receptor (CD3)-stimulated transmembrane signal transduction in purified subsets of human peripheral blood lymphocytes. Toxicol. Appl. Pharmacol. 119:1993;91-99.
21. Kawabata T. T., White K. L. Suppression of thein vitro. Cancer Res. 47:1987;2317-2322.
22. Krieger J. A., Born J. L., Burchiel S. W. Persistence of calcium elevation in the HPB-ALL human T cell line correlates with the immunosuppressive properties of polycyclic aromatic hydrocarbons. Toxicol. Appl. Pharmacol. 127:1994;268-274.
23. Krieger J. A., Davila D. R., Lytton J., Born J. L., Burchiel S. W. Inhibition of sarcoplasmic/endoplasmic reticulum calcium ATPases (SERCA) by polycyclic aromatic hydrocarbons in HPB-ALL human T cells and other tissues. Toxicol. Appl. Pharmacol. 133:1995;102-108.
24. Li Q., Geiselhart L., Mittler J. N., Mudzinski S. P., Lawrence D. A., Freed B. M. Inhibition of human T lymphoblast proliferation by hydroquinone. Toxicol. Appl. Pharmacol. 139:1996;317-323.
25. Meister A., Anderson M. E. Glutathione. Annu. Rev. Biochem. 52:1983;711-760.
26. Merchant M., Krishnan V., Safe S. Mechanisms of action of α-napthoflavone as an Ah receptor antagonist in MCF-7 human breast cancer cells. Toxicol. Appl. Pharmacol. 120:1993;179-185.
27. Messina J. P., Lawrence D. A. Cell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phase. J. Immunol. 114:1989;1974-1981.
28. Morrison H., Di Monte D., Nordenskjold, Jernstrom B. Induction of cell damage be menadione and benzo(a)pyrene-3,6-quinone in cultures of rat hepatocytes and human fibroblasts. Toxicol. Lett. 28:1985;37-47.
29. Morrison H., Hammarskold V., Jernstrom B. Status of reduced glutathione in primary cultures of rat hepatocytes and the effect of conjugation of benzo(a)pyrene-7,8-dihydrodiol-9,10-oxide. Chem.-Biol. Interact. 45:1983;235-242.
30. B. J. Mounho, D. R. Davila, S. W. Burchiel, Characterization of intracellular calcium responses produced by polycyclic aromatic hydrocarbons in surface marker-defined human peripheral blood mononuclear cells.
31. Mudzinsky S. P. Effects of benzo(a)pyrene on concanavallin A-stimulated human peripheral blood mononuclear cellsin vitro: Toxicol. Appl. Pharmacol. 120:1993;179-185.
32. Murty V. S., Penning T. M. Polycyclic aromatic hydrocarbons (PAH) ortho-quinone conjugate chemistry: Kinetics of thiol addition to PAH ortho-quinones and structures of thioether adducts of napthalene-1,2-dione. Chem.-Biol. Interact. 84:1992;169-188.
33. Nel A. E., Wooten M. W., Galbraith R. M. Molecular signaling mechanisms in T-lymphocyte pathways: A review and future prospects. Clin. Immunol. Immunopathol. 44:1987;167-186.
34. ++. FEBS Lett. 181:1985;149-153.
35. Nicotera P., Bellomo G., Orrenius S. Calcium-mediated mechanisms in chemically induced cell death. Annu. Rev. Pharmacol. Toxicol. 32:1992;449-470.
36. Novak E. J., Rabinovitch P. S. Improved sensitivity in flow cytometric intracellular ionized calcium measurements using Fluo-3/Fura-red fluorescence ratios. Cytometry. 17:1994;135-141.
37. Okano P., Miller H. N., Robinson R. C., Gelboin H. V. Comparison of Benzo(a)pyrene and (-)-trans-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene metabolism in human blood monocytes and lymphocytes. Cancer Res. 39:1979;3184-3193.
38. ++. Arch. Biochem. Biophys. 263:1988;226-235.
39. Ou X., Weber T. J., Chapkin R. S., Ramos K. S. Interference with protein kinase C-related signal transduction in vascular smooth muscle cells by benzo[a]pyrene. Arch. Biochem. Biophys. 318:1995;122-130.
40. Pickett C. B., Lu A. Y. H. Glutathione S-transferases: Gene structure, regulation, and biological function. Annu. Rev. Biochem. 58:1989;743-764.
41. Recio L., Hsie A. W. Modulation of the cytotoxicity and mutagenicity of benzo(a)pyrene and benzo(a)pyrene-7,8-diol by glutathione and glutathione S-transferase in mammalian cells (CHO/HGPRT assay). Mutat. Res. 178:1987;257-269.
42. Reed D. J. Glutathione: Toxicological implications. Annu. Rev. Pharmacol. Toxicol. 30:1990;603-631.
43. Reed D. J., Babson J. R., Beatty P. W., Brodie A. E., Potter D. W. High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfides. Anal. Biochem. 106:1980;55-62.
44. Robertson I. G., Jernstrom B. The enzymatic conjugation of glutathione with bay region diol-epoxides of benzo(a)pyrene, benz(a)anthracene, and chrysene. Carcinogenesis. 7:1986;1633-1636.
45. 2+. J. Biol. Chem. 268:1993;16688-16692.
46. Smyth M. J. Glutathione modulates activation-dependent proliferation of human peripheral blood lymphocyte populations without regulating their activated function. J. Immunol. 146:1991;1921-1927.
47. Staal F. J. T., Anderson M. T., Staal G. E. J., Herzenberg L. A., Gitler C., Herzenberg L. A. Redox regulation of signal transduction: Tyrosine phosphorylation and calcium flux. Proc. Natl. Acad. Sci. USA. 91:1994;3619-3622.
48. Staruch M. J., Sigal N. H., Dumont F. J. Differential effects of the immunosuppressive macrolides FK-506 and rapamycin on activation-induced T-cell apoptosis. Int. J. Immunopharmacol. 13:1991;677-685.
49. 2+2+. Proc. Nat. Acad. Sci. USA. 87:1990;2466-2470.
50. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues. Anal. Biochem. 27:1969;502-522.
51. Trush M. A., Twerdock L. E., Esterline R. L. Comparison of oxidant activities and the activation of benzo(a)pyrene-7,8-dihydrodiol by polymorphonuclear leukocytes from human, rat and mouse. Xenobiotica. 9:1990;925-932.
52. Twerdock L. E., Mosebrook D. R., Truch M. A. Comparison of oxidant-generation and BP-diol activation by bone marrow cells from C57B1/6 and DBA/2 mice: Implications for risk of bone marrow toxicity induced by polycyclic aromatic hydrocarbons. Toxicol. Appl. Pharmacol. 112:1992;266-272.
53. Walsh A. C., Michaud S. G., Malossi J. A., Lawrence D. A. Glutathione depletion in human T lymphocytes: Analysis of activation-associated gene expression and the stress response. Toxicol. Appl. Pharmacol. 133:1995;249-261.
54. Whitlock J. P., Cooper H. L., Gelboin H. V. Aryl hydrocarbon (benzopyrene) hydroxylase is stimulated in human lymphocytes by mitogens and benz(a)anthracene. Science. 177:1972;618-619.
55. Yu B. P. Cellular defenses against damage from oxygen species. Physiol. Rev. 74:1994;139-162.
56. Yuan J. W., Krieger J. A., Maples K. R., Born J. L., Burchiel S. W. Polycyclic aromatic hydrocarbons decrease intracellular glutathione levels in the A20.1 murine B cell lymphoma. Fundam. Appl. Pharmacol. 23:1994;336-341.
57. Zhao M., Lytton J., Burchiel S. W. Inhibition of sarco-endoplasmic reticulum calcium ATPases (SERCA) by polycyclic aromatic hydrocarbons. Lack of evidence for direct effects on cloned rat enzymes. Int. J. Immunopharmacol. 18:1997;589-598.
58. Zhu H., Li Y., Trush M. A. Characterization of benzo(a)pyrene quinone-induced toxicity to primary bone marrow stromal cells from DBA/2 mice: Potential role of mitochondrial dysfunction. Toxicol. Appl. Pharmacol. 130:1995;108-120.